Prelude Therapeutics Inc 10-K for FY2025
Prelude Therapeutics Inc (PRLD)
10-K
2026-03-10
For: 2025-12-31
View Original
Added on
April 06, 2026
About this 10-K
Prelude Therapeutics Inc filed this 10-K on March 10, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $12.14M
- up 73.4% from $7M a year earlier
- Net loss
- $99.5M
- compared with a net loss of $127.17M a year earlier
- Diluted EPS
- -$1.29
- compared with -$1.68 a year earlier